Propentofylline for dementia (Q24248786)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Propentofylline for dementia (English)

0 references

0 references

Maria A Frampton

1

0 references

Richard J Harvey

series ordinal

2

0 references

Vincent Kirchner

series ordinal

3

0 references

publication date

22 April 2003

0 references

published in

0 references

cites work

Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Propentofylline treatment for Alzheimer disease and vascular dementia: an economic evaluation based on functional abilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Placebo-controlled trial of the xanthine derivative propentofylline in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Clinical Trials in Dementia with Propentofyllinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Cytotoxicity of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853

A new rating scale for dementia syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD002853